“ A very difficult conversation ”: Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Kendall Carpenter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Boston Combined Residency Program, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Neoplasms, Communication. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Children's Cancer Research Fund, St. Baldrick's Foundation.
Abstract (Originalsprache)
Objectives
Current approaches to communicating the potential late effects of pediatric oncology treatments leave many patients and families feeling unaware of risks and unprepared for the future. We aimed to identify provider perspectives on early communication about late effects.
Methods
Semi‐structured interviews were conducted with pediatric oncology providers at Dana‐Farber/Boston Children's Cancer and Blood Disorders Center from December 2021 to March 2022. Purposeful sampling ensured a diversity of clinical roles. Thematic analysis was conducted using deductive and inductive codes.
Results
We interviewed nine pediatric oncology providers; all expressed discomfort discussing potential late effects in early treatment conversations. Barriers to late effects communication included (i) social‐emotional factors, including lack of perceived importance to families, worry about emotional burden on families, and provider feelings of helplessness/wanting to provide hope; and (ii) suboptimal set‐up/resources, including limitations of consent forms, time constraints, and lack of available data. All providers supported the creation of a communication tool to assist early discussions of late effects.
Conclusions
Communicating about late effect risks poses unique challenges to providers because of the perceived impact on families and the limitations of current practices and available resources. These findings support the need for a late effects communication tool to assist in early communication about late effects risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boston Combined Residency Program, Boston, Massachusetts, USA.
- Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Jennifer W Mack
Förderung
- NCI NIH HHS
- Children's Cancer Research Fund
- St. Baldrick's Foundation
- Conquer Cancer Foundation
Zitieren
APA
Carpenter, K., Revette, A. C., Scavotto, M., Mack, J. W., & Greenzang, K. A. (2024). “ A very difficult conversation ”: Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31093
Vancouver
Carpenter K, Revette AC, Scavotto M, Mack JW, Greenzang KA. “ A very difficult conversation ”: Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31093
BibTeX
@article{Carpenter2024,
author = {Carpenter, Kendall and Revette, Anna C and Scavotto, Madison and Mack, Jennifer W and Greenzang, Katie A},
title = {“ A very difficult conversation ”: Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31093}
}
EUVIMED